ADHD环境风险因素、保护因素与外周生物标志物的伞形综述
该伞形综述纳入35篇系统综述的63项荟萃分析,评估ADHD环境风险、保护因素及外周标志物证据。母亲孕前肥胖、儿童湿疹、妊娠高血压疾病、子痫前期及孕期对乙酰氨基酚暴露与ADHD关联证据为可信(I级);孕期吸烟、儿童哮喘、孕前超重及血清维生素D关联为高度提示(II级)。
要点
- 母亲孕前肥胖、妊娠高血压疾病、子痫前期及孕期对乙酰氨基酚暴露与ADHD关联证据为I级。
- 孕期吸烟、儿童哮喘、孕前超重及血清维生素D与ADHD关联证据为II级。
- 孕前肥胖、超重及孕期吸烟的关联可能受家族或遗传因素混杂,因果关系需高质量研究证实。
核心结论
- 母亲孕前肥胖和超重、子痫前期、妊娠高血压、孕期对乙酰氨基酚暴露及孕期吸烟,以及儿童特应性疾病与ADHD强烈相关。
- 既往家族研究提示孕前肥胖、超重及孕期吸烟的关联受家族或遗传因素混杂,需进一步高质量研究确立因果关系。
研究设计与样本
- 计算汇总效应量(OR、RR、WMD、Cohen's d、Hedges' g)、95%CI、异质性I2、95%预测区间、小研究效应和过度显著性偏倚,并采用可信度天花板和AMSTAR 2评估质量。
关键数值与推荐
- 证据分级:I级为可信,II级为高度提示。
临床怎么用
- 临床可关注母亲孕前肥胖、妊娠高血压疾病、子痫前期、孕期对乙酰氨基酚暴露及孕期吸烟等与ADHD关联较强的因素。
- 儿童湿疹和哮喘与ADHD关联证据较强,提示对特应性疾病患儿可关注ADHD相关表现。
- 血清维生素D与ADHD关联为高度提示,但当前证据尚不足以支持因果干预。
局限性
- 孕前肥胖、超重及孕期吸烟与ADHD的关联可能受家族或遗传因素混杂,因果关系尚未确立。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Many potential environmental risk factors, environmental protective factors, and peripheral biomarkers for ADHD have been investigated, but the consistency and magnitude of their effects are unclear. We aimed to systematically appraise the published evidence of association between potential risk factors, protective factors, or peripheral biomarkers, and ADHD. METHODS: In this umbrella review of meta-analyses, we searched PubMed including MEDLINE, Embase, and the Cochrane Database of Systematic Reviews, from database inception to Oct 31, 2019, and screened the references of relevant articles. We included systematic reviews that provided meta-analyses of observational studies that examined associations of potential environmental risk factors, environmental protective factors, or peripheral biomarkers with diagnosis of ADHD. We included meta-analyses that used categorical ADHD diagnosis criteria according to DSM, hyperkinetic disorder according to ICD, or criteria that were less rigorous than DSM or ICD, such as self-report. We excluded articles that did not examine environmental risk factors, environmental protective factors, or peripheral biomarkers of ADHD; articles that did not include a meta-analysis; and articles that did not present enough data for re-analysis. We excluded non-human studies, primary studies, genetic studies, and conference abstracts. We calculated summary effect estimates (odds ratio [OR], relative risk [RR], weighted mean difference [WMD], Cohen's d, and Hedges' g), 95% CI, heterogeneity I2 statistic, 95% prediction interval, small study effects, and excess significance biases. We did analyses under credibility ceilings, and assessed the quality of the meta-analyses with AMSTAR 2 (A Measurement Tool to Assess Systematic Reviews 2). This study is registered with PROSPERO, number CRD42019145032. FINDINGS: We identified 1839 articles, of which 35 were eligible for inclusion. These 35 articles yielded 63 meta-analyses encompassing 40 environmental risk factors and environmental protective factors (median cases 16 850, median population 91 954) and 23 peripheral biomarkers (median cases 175, median controls 187). Evidence of association was convincing (class I) for maternal pre-pregnancy obesity (OR 1·63, 95% CI 1·49 to 1·77), childhood eczema (1·31, 1·20 to 1·44), hypertensive disorders during pregnancy (1·29, 1·22 to 1·36), pre-eclampsia (1·28, 1·21 to 1·35), and maternal acetaminophen exposure during pregnancy (RR 1·25, 95% CI 1·17 to 1·34). Evidence of association was highly suggestive (class II) for maternal smoking during pregnancy (OR 1·6, 95% CI 1·45 to 1·76), childhood asthma (1·51, 1·4 to 1·63), maternal pre-pregnancy overweight (1·28, 1·21 to 1·35), and serum vitamin D (WMD -6·93, 95% CI -9·34 to -4·51). INTERPRETATION: Maternal pre-pregnancy obesity and overweight; pre-eclampsia, hypertension, acetaminophen exposure, and smoking during pregnancy; and childhood atopic diseases were strongly associated with ADHD. Previous familial studies suggest that maternal pre-pregnancy obesity, overweight, and smoking during pregnancy are confounded by familial or genetic factors, and further high-quality studies are therefore required to establish causality. FUNDING: None.
引用
- Kim JH, Kim JY, Lee J, et al. Environmental risk factors, protective factors, and peripheral biomarkers for ADHD: an umbrella review. Lancet Psychiatry. 2020. PMID: 33069318. doi:10.1016/S2215-0366(20)30312-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。